These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 14634768)

  • 21. Fabry's disease with LVOT obstruction: diagnosis and management.
    Blount JR; Wu JK; Martinez MW
    J Card Surg; 2013 Nov; 28(6):695-8. PubMed ID: 23992477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac manifestations of Fabry's disease: a story of mother and son.
    Moses H; Yarnoz MJ; Guglin M
    Congest Heart Fail; 2009; 15(2):93-5. PubMed ID: 19379456
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiologic and neurologic findings in left ventricular hypertrabeculation/noncompaction relating to echocardiographic indication.
    Stöllberger C; Winkler-Dworak M; Blazek G; Finsterer J
    Int J Cardiol; 2007 Jun; 119(1):28-32. PubMed ID: 17023079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabry disease female proband with clinical manifestations similar to hypertrophic cardiomyopathy.
    Teragaki M; Tanaka A; Akioka K; Lan HT; Nishi Y; Yamano T; Yoshikawa J
    Jpn Heart J; 2004 Jul; 45(4):685-9. PubMed ID: 15353880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological detection of intramyocardial abscesses in Candida sepsis mimicking left ventricular non-compaction/hypertrabeculation on echocardiography.
    Stöllberger C; Preiser J; Finsterer J
    Mycoses; 2004 Feb; 47(1-2):72-5. PubMed ID: 14998404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fabry's disease with isolated disease of the cardiac muscle, manifesting as hypertrophic cardiomyopathy].
    Elleder M; Dorazilová V; Bradová V; Bĕlohlávek M; Král V; Choura M; Budĕsínský M; Harzer K
    Cas Lek Cesk; 1990 Mar; 129(12):369-72. PubMed ID: 2111224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac variant of Fabry's disease mimicking hypertrophic cardiomyopathy.
    Chimenti C; Ricci R; Pieroni M; Natale L; Russo MA; Frustaci A
    Cardiologia; 1999 May; 44(5):469-73. PubMed ID: 10389354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry's disease during enzyme-replacement therapy.
    Prinz C; Farr M; Hering D; Horstkotte D; Faber L
    Clin Res Cardiol; 2010 Jan; 99(1):53-5. PubMed ID: 19774328
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of heterozygous Fabry's disease with a short PR interval and giant negative T waves.
    Yokoyama A; Yamazoe M; Shibata A
    Br Heart J; 1987 Mar; 57(3):296-9. PubMed ID: 3105563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiological follow-up in patients with Fabry disease].
    Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
    G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Finsterer J
    J Am Soc Echocardiogr; 2004 Jan; 17(1):91-100. PubMed ID: 14712196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical diagnosis of Fabry's disease by fluorometric assay and fast atom bombardment/mass spectrometry.
    Nakanishi T; Funahashi S; Funai T; Hashimoto T; Shimizu A
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():368-72. PubMed ID: 1654042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for Fabry disease in patients with left ventricular hypertrophy.
    Mawatari K; Yasukawa H; Oba T; Nagata T; Togawa T; Tsukimura T; Kyogoku S; Ohshima H; Minami T; Sugi Y; Sakuraba H; Imaizumi T
    Int J Cardiol; 2013 Aug; 167(3):1059-61. PubMed ID: 23168011
    [No Abstract]   [Full Text] [Related]  

  • 34. Alpha-galactosidase A deficiency (Fabry's disease) in a black Zimbabwean.
    Borok MZ; Gabriel R
    S Afr Med J; 1993 May; 83(5):350-1. PubMed ID: 8211434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patients.
    Massaccesi L; Burlina A; Baquero CJ; Goi G; Burlina AP; Tettamanti G
    Clin Biochem; 2011 Jul; 44(10-11):916-21. PubMed ID: 21515249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fifteen-year follow-up of a heterozygous Fabry's disease patient associated with pre-excitation syndrome.
    Murata R; Takatsu H; Noda T; Nishigaki K; Tsuchiya K; Takemura G; Kanoh M; Kunishima A; Sano K; Minatoguchi S; Takagi H; Fujiwara H
    Intern Med; 1999 Jun; 38(6):476-81. PubMed ID: 10411352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relief of left ventricular outflow obstruction by cibenzoline in a patient with Fabry's disease--a case report.
    Morimoto S; Sugiura A; Iwase M; Kubo N; Hiramitsu S; Uemura A; Ohtsuki M; Kato S; Kato Y; Hishida H
    Angiology; 2006; 57(2):241-5. PubMed ID: 16518535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fabry's disease; towards a treatment].
    Linthorst GE; Hollak CE; Bosman DK; Heymans HS; Aerts JM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2391-5. PubMed ID: 11145093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
    N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ocular findings in Fabry's disease].
    Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J
    Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.